Novartis Animal Health UK Ltd has announced the launch of CLiKZiN Pour On for sheep, a short meat withhold period (MWP) product that can be used throughout Spring and Summer for the prevention of blowfly strike in sheep and lambs.
CLiKZiN is a ready-to-use water-based product that protects sheep for eight weeks, and has a meat withhold period of seven days. The product is a line extension of CLiK which offers a longer period of protection at 16 weeks and has a longer withhold period of 40 days. Novartis says that used in conjunction with CLiK, CLiKZiN offers versatile protection throughout the year.
The launch of CLiKZiN comes at the same time that Vetrazin has been reformulated, resulting in a longer meat withhold period for sheep treated with the product.
Thomas Tiley MRCVS from Novartis Animal Health said: "Farmers need reliable protection from the repugnant threat of blowfly strike. CLiKZiN provides eight weeks blowfly prevention together with the trusted performance and safety record associated with CLiK. It also offers the greater flexibility of a seven day meat withhold.
"This makes CLiKZiN ideally suited for a variety of production schedules and stock including lambs for slaughter and pre-shearing ewes."
Blowfly strike can be devastating to sheep, causing severe impact on the welfare of the animal. Within days of a blowfly laying its eggs, clinically normal sheep can be afflicted with flesh eating maggots. This makes prompt and effective treatment critical.
National Sheep Association Chief Executive Peter Morris said: "Fly strike is a terrible burden to the sheep industry both in terms of the welfare of the sheep and economically.
"Having a product available that gives effective prevention against fly strike whilst at the same time having a withdrawal period which does not impinge on the ability of the sheep farmer to market lambs is very welcome. The sheep farmers' armoury against the every day afflictions which affect sheep has been significantly enhanced."
Vetoquinol UK has launched Sodium Salicyl 80%, a water soluble, non-steroidal anti-inflammatory drug (NSAID).
Sodium Salicyl 80% contains 800mg of sodium salicylate and is indicated for supportive treatment of pyrexia in acute respiratory disease in calves (of at least two weeks of age). In pigs, Sodium Salicyl 80% is indicated for the treatment of inflammation, in combination with concurrent antibiotic therapy. Vetoquinol says that unlike acetylsalicylic acid (conventional aspirin) which is poorly soluble in water, sodium salicylate is highly water soluble (1 g/ml water), even in the hard water commonly encountered in the UK which makes it ideal for group therapy in any herd.
Sodium Salicyl 80% can be administered orally through the milk replacer or drinking water. Orally administered salicylates are absorbed rapidly and make it easier to treat groups of pigs and calves suffering from stress.
Vetoquinol says it's well known that any focus of pain or discomfort is likely to reduce an animals' feed and water intake, enough to reduce performance and potentially increase the need for the use of antibiotics. NSAID's are ideal for use in times of stress, for example after weaning where they have the ability to reduce inflammation, provide analgesia and reduce pyrexia. Unlike corticosteroids, NSAID's relieve pain and inflammation without the immunosuppressive and metabolic side effects. Stress is a known cause for an acute phase response (inflammation) and viral and bacterial infections are common in this vulnerable period.
Susan Mitchell, Large Animal Product Manager at Vetoquinol said: 'We are delighted to be expanding our large animal range with Sodium Salicyl 80%. We are now able to offer vets and producers a solution for both individual and group situations where an NSAID is required"
The new vaccine offers up to 12 months' immunity against three of the biggest diseases that cause reproductive failures in pigs.
Alexandre Carvalho, business unit manager for pigs at MSD Animal Health, says the vaccine has the broadest protection against Leptospira on the market, offering protection against nine different serogroups including, Australis and Pomona.
He added: "This vaccine also includes protection against the Tarassov serogroup, which is unique to the product.
"It’s important to note that PORCILIS Ery+Parvo+Lepto can be used for mass vaccination and during pregnancy, which hasn’t been possible with previous products."
Vetoquinol UK Limited has launched Kefloril, containing 300mg/ml florfenicol for use in cattle and pigs in 100ml and 250ml vials.
In cattle, Kefloril is licensed for preventative and therapeutic treatment of respiratory tract infections. In pigs, Kefloril is licensed for the treatment of acute outbreaks of respiratory disease. Kefloril has the added benefit of traceability stickers which are attached to each vial, designed to make it easier and quicker to record and monitor on-farm usage.
Vetoquinol says the addition of Kefloril to its anti-infective domain provides a cost-effective treatment for respiratory cases this winter.
This, says the government, would be one of the toughest sanctions in Europe, strengthening the country's claim to be a global leader on animal welfare.
The Animal Welfare (Sentencing) Bill comes after a public consultation held last year which found that more than 70% of people supported proposals for tougher prison sentences. It will allow the courts to take a tougher stance on things like dog fighting, puppy and kitten abuse, and neglect of farm animals.
The new Bill has been welcomed by animal welfare charities.
Chief Executive for the RSPCA, Chris Sherwood, said: "This reform is long overdue. Those responsible for extreme cruelty towards animals or those criminal gangs involved in organised animal crime will now face the tough justice they deserve.
"We need to better protect our animals and the RSPCA hopes that this new Animal Welfare (Sentencing) Bill will give courts the powers they need to punish those responsible for the most unimaginable cruelty to animals.
"We also believe this will act as a much stronger deterrent to others and help us stamp out animal cruelty once and for all."
James Yeates, Cats Protection’s Chief Executive said: "We very much welcome this announcement which is an important step in ensuring the UK is one of the world leaders on animal welfare issues.
Claire Horton, Chief Executive of Battersea Dogs & Cats Home, said: "The introduction of this bill is a landmark achievement, which will make a profound difference to dogs and cats in England and Wales."
The latest figures from 2017/18 reveal that over 120 million animals were slaughtered in England and Wales without being stunned first1.
In an open letter to Environment Secretary Michael Gove, the BVA and the RSPCA urge the UK Government to change legislation in England which currently allows non-stun slaughter for religious purposes, and provide further public transparency on this issue by releasing the comprehensive 2018 slaughter survey results, which Mr Gove himself signalled would be published by Autumn 2018.
Until such legislation is in place the RSPCA and BVA are calling for:
meat to be labelled with the method of slaughter, e.g. stunned or non-stunned, so consumers are fully informed about the meat that they are buying.
non-stun slaughter to only be permitted at levels that meet local religious community demand for this type of meat in the interests of limiting animal pain and suffering.
a ban on export of meat from non-stunned animals or live animals destined for non-stun slaughter.
an immediate post-cut stun for cattle, sheep, goats and deer to reduce the period of pain and distress.
The letter follows a recent, high profile decision to ban the slaughter of animals without prior stunning in the Flanders region of Belgium which came into force at the start of the year. Belgium joins several other European countries, including Iceland, Sweden, Switzerland and Denmark in making this decision, demonstrating that a full ban on non-stun slaughter is possible within EU law.
RSPCA chief executive, Chris Sherwood said: "Until there is a change in the law to end non-stun slaughter, there are several measures the UK Government could introduce to reduce the suffering involved in this practice. For example, by ensuring trade deals with other countries do not include non-stun meat or live animals for non-stun slaughter, clear labelling should be adopted to enable consumers to make an informed choice about the meat they buy and how it was slaughtered."
BVA President Simon Doherty said: "The UK Government has repeatedly stated it would prefer to see all animals stunned before slaughter but has taken no action to address this critical welfare issue that affects millions of animals every year. It is doubly disappointing that data that would have provided a valuable benchmark for levels of non-stun slaughter in the UK has yet to see the light of day despite assurances throughout last year that it would soon be made public.
"There is a huge groundswell of support for a ban on non-stun slaughter, and recent developments in Belgium show that decisive change is possible where public support is matched by political will. Michael Gove has made clear that he wants to maintain and build on the UK’s reputation as global leader on animal welfare; banning non-stun slaughter is a surefire way of showing he will deliver on this commitment.
"If slaughter without stunning continues to be permitted in the UK, then meat and fish from this source must be clearly labelled, to help customers make informed choices about the food that they buy and eat."
You can sign the open letter at: www.rspca.org.uk/endnonstun and join the online debate using the hashtag #EndNonStun.
Evidence-Based Veterinary Medicine Matters: Our Commitment to the Future represents the first time that such a broad and influential group has united in support of a single issue in the veterinary profession.
The publication contains a number of case studies which illustrate the impact that evidence can have – and has had – on animal health and welfare. It also provides a rationale for veterinary professionals to contribute to the evidence base and put evidence into practice, to the benefit of animals, owners and veterinary teams themselves.
The signatories to the commitment are:
Animal and Plant Health Agency
British Cattle Veterinary Association
British Equine Veterinary Association
British Small Animal Veterinary Association
British Veterinary Association
British Veterinary Nursing Association
RCVS Knowledge
Royal College of Veterinary Surgeons (RCVS)
Royal Veterinary College
University of Bristol
University of Cambridge
University of Liverpool
University of Nottingham
University of Surrey
Veterinary Policy Research Foundation
No sign of the BAHVS, I see.
Jacqui Molyneux, Chair of the Board of Trustees of RCVS Knowledge, said: "Evidence-Based Veterinary Medicine Matters is a milestone publication for the professions, representing the first time the majority of the key institutions have aligned under the same EBVM banner.
"A celebration of decades of incredible discoveries, achievements and improvements in animal health, it also serves to remind us that even the earliest forms of veterinary medicine were underpinned by evidence."
UK Chief Vet Christine Middlemiss said: "What’s the evidence? An evidence-based approach is vital in all areas of our profession, whatever is keeping you awake at night. For me, it is the threat of African swine fever and avian flu. The evidence I rely on comes from our specialist surveillance monitoring and testing, veterinary epidemiologists and disease modellers. It enables me to make timely, proportionate risk-based decisions that stand up to scrutiny.
"If you are managing veterinary care in practice, the evidence you rely on to underpin your standards of clinical care comes from multiple sources too. Evidence-based veterinary medicine allows us to refine and tailor strategies to be effective and efficient, making full use of existing and new technologies.
"The profession has taken great strides towards embracing evidence-based veterinary medicine and building on this will strengthen the links between clinical decision-making, policy development and future research."
Chris Gush, Executive Director of RCVS Knowledge, added: "We are impressed by the contributions from our co-signatories, which clearly demonstrate the phenomenal impact on patient outcomes that conducting research and using evidence can have. We are also delighted that Sense about Science, a flagbearer for evidence, transparency and rational thinking, has joined with us to highlight the many benefits EBVM can bring.
"The publication also makes a strong case for much-needed funding for research to grow the evidence base, which would put powerful, robust data into the hands of veterinary professionals as they make critical decisions that can affect patient outcomes.
"It is our hope that the calibre, diversity and sheer number of the organisations putting their name to this commitment will galvanise all vets and their teams to expand their use of evidence in practice."
Rebecca Asher, Deputy Director at Sense about Science, said: "This is a showcase of game changers in veterinary care and we hope it will inspire and motivate everyone in the profession.
"We were delighted that RCVS Knowledge approached us to collaborate with them and other leading institutions in the veterinary research community to affirm their commitment to an evidence-based approach to veterinary medicine.
"Everyone expects treatment for humans to be underpinned by evidence. We now expect the same of the whole veterinary community when it comes to the treatment of animals."
The full commitment and portfolio of case studies can be read in Evidence-Based Veterinary Medicine Matters, available for free online: bit.ly/EBVMMatters.
Elanco Animal Health has announced that there have been extensions to the withdrawal periods for Dectomax (doramectin) 10 mg/ml Solution for Injection and Micotil (tilmicosin) 300 mg/ml Solution for Injection.
For Dectomax injectable, meat withdrawal for cattle and sheep will be extended to 70 days and pigs to 77 days. For Micotil, sheep milk withdrawal will be extended to 18 days and milk from cows during the dry period or from pregnant heifers should not be used for human consumption until 36 days after calving.
Elanco is reminding veterinary surgeons and SQPs that they may continue to prescribe according to the current label but it is good practice to implement revised withdrawal periods. The company is also taking this opportunity to highlight the importance of getting into the habit of double-checking withdrawal periods when administering drugs, because they do change from time to time in the light of new knowledge.
Bovalto Respi 3 contains strains of parainfluenza virus 3, bovine respiratory syncytial virus and Mannheimia haemolytica serotype A1.
Bovalto Respi 4 combines the three pathogens in Bovalto Respi 3, with the addition of bovine viral diarrhoea virus.
According to the company, calf pneumonia costs are around £43/€49* per dairy calf and £82/€93* per suckler calf1.
Boehringer’s vet adviser Ailsa Milnes said: "The majority of these costs are made up of mortality, slower growth rates and reduced lifetime performance.
"It is worth remembering that calf pneumonia can cause irreversible damage to the lungs which means that, even if the animal recovers, its lifetime performance suffers and it will be more susceptible to disease in the future.
"Bovalto Respi 3 and Bovalto Respi 4 are the only vaccines available to demonstrate six months of immunity by challenge for all pathogens, and calves develop protective immunity three weeks after completion of the primary vaccination course.
"Now, with the added flexibility of being able to administer the vaccines to pregnant cattle, the overall level of respiratory disease in a herd will hopefully fall and overall health status improve as a result."
Reference
For the study1, 158 cows presented with active DD (M1, M2 or M4.1 stage) and were randomly allocated to either the control or the treatment group.
All cows were treated with a topical application of oxytetracycline spray.
The treatment group also received an intramuscular injection of Ketofen 10% solution for injection (ketoprofen 3mg/kg).
Cows were mobility scored just before they were treated and then again one week later.
The results indicated that animals in the control group were 2.57 times more likely to be lame at the second evaluation compared to those that received Ketofen, however cows that were lame in the control group prior to treatment and did not receive Ketofen were over 20 times more likely to remain lame a week post-treatment compared to cows that did receive Ketofen.
The same study all showed a milk yield benefit overall; treated cows produced 2.98 kg more milk than control cows (T = 45.35 C = 42.37, p<0.01).
When only lame fresh cows were considered, there was a 10.49kg increase in milk yield (T = 58.38 C = 47.89 p<0.05).
Nick Bell MA, VetMB, PhD, PGCert Vet Ed, FHEA, DipECAWBM(AWSEL), MRCVS, veterinary surgeon and director of Herd Health Consultancy, said: “We’ve widely recognised the importance of NSAIDs for treating claw lesions, which are primarily inflammatory conditions, but this study is the first real insight into how important NSAIDs are for any lesion, including digital dermatitis, particularly if the cow is showing signs of lameness.
"This research provides a clear welfare justification for giving NSAIDs to dairy cows with active digital dermatitis lesions, with significant milk yield benefits.”
Katherine Timms BVetMed(Hons) MRCVS, ruminant veterinary advisor at Ceva Animal Health said: “While it is recognised that some stages of digital dermatitis are painful, there has been little research to determine the value of including analgesia in the treatment of the condition.
“This study suggests that the use of Ketofen in the treatment of pain and lameness associated with active digital dermatitis lesions may be beneficial for animal welfare as it is associated with an improvement in mobility scores.”
A sign up section where Official Veterinarians (OVs) can register to continue providing bTB testing with aspiring Delivery Partner Xperior Farm Health under AHVLA's Veterinary Delivery Partnership programme has been added to Xperior's website (www.xperiorfarmhealth.co.uk/vets/).
Xperior Farm Health is the joint venture between Eville & Jones and Westpoint Veterinary Group that is one of the declared bidders for appointment by AHVLA as a Delivery Partner. Veterinary Director Phil Elkins said: "If appointed, we are fully committed to maintaining sub-contractor OV involvement."
As alternatives to website sign up, OVs can also do so by email (phil.elkins@xperiorfarmhealth.co.uk) or post using either a printed form that was mailed recently to more than 1,000 farm vets or by writing to Mr Elkins at Century House, Thorpe Park, Leeds LS15 8ZB.
To give experienced OVs an opportunity to influence the Delivery Partner bid, Xperior have also extended their online survey (https://www.surveymonkey.com/s/PQFSWZN) until the end of July.
Phil added: "If appointed, our commitment is to provide an exemplary standard of accurate and trustworthy on-farm animal health testing services, where possible using subcontracted practices. These will be farmer friendly, provide an ongoing source of work and revenue to subcontractor Official Veterinarians, and represent excellent value for money to the taxpayer."
Elanco has launched a new poultry tonic designed to support birds during the most demanding periods of productivity: during growth and peak laying.
The launch follows Elanco's acquisition of Janssen Animal Health and its existing poultry poultry tonic, which Elanco has improved.
Elanco Poultry Tonic HD Plus contains two new ingredients: a vitamin D3 metabolite and a natural antioxidant blend.
Elanco says the new product could prove just the tonic for the poultry industry in the face of rising fuel and feed costs. One study has apparently demonstrated as much as a 5:1 return on investment can be made as a result of supplementing the D3 metabolite alone.1According to the company, the vitamin D3 metabolite has been shown to increase egg weights (by around 2 per cent) and improve feed conversion and feed intake. It is more available to the body than vitamin D3, which plays a role in calcium metabolism (and therefore egg production). The benefits are significant for commercial egg producers but also for hatcheries, as egg size correlates with chick weight. Elanco says the metabolite can also improve bone strength, potentially resulting in healthier, more robust poults.The new antioxidant blend contains natural preparations of vitamins as well as more complex antioxidants found in fruits and vegetables, such as flavanoids, polyphenols and carotenoids. It also contains nucleotides and sulphur containing amino acids, methionine and lysine. Elanco's new Poultry Tonic HD Plus is suitable for layers, broilers, breeders and turkeys and is available from veterinary wholesalers and animal health distributors. The company is also launching Game Bird Tonic HD Plus at the same time.
1. SOTO-SALANOVA MF MOLINERO A, Efficacy of the use of Hy-D® in laying hens, XI th European Symposium on the Quality of Eggs and Egg Products 191 Doorwerth, The Netherlands, 23-26 May 2005
Chanelle has announced the launch of Ketamidor 100 mg/ml Solution for Injection (ketamine), licensed for use in cats, dogs, horses, cattle and swine in the UK and Ireland.
The company says the new product provides a versatile addition to anaesthetic regimes. It can be used in combination with other widely-used anaesthetics and sedatives. Chanelle says it also has analgesic properties that make it particularly beneficial to include in anaesthetic protocols when carrying out painful surgical procedures.
Ketamidor 100mg/ml Solution for Injection has a zero day withdrawal period for milk and meat when used in cattle and pigs, allowing high welfare standards to be maintained without compromising economic returns.
According to Chanelle, ketamine is now experiencing a resurgence of interest as its analgesic properties and minimal impact on spontaneous respiration become increasingly appreciated.1
Angela Wilkin, Chanelle UK's Sales and Marketing Manager said: "Ketamidor makes a great addition to our portfolio of pain management products. Our territory managers are looking forward to speaking to those vets who are already accustomed to using ketamine and those that may be considering adding it to their current protocols."
The programme gives farmers and veterinary surgeons access to new resources, enabling a coordinated and consistent approach to farmer training in the responsible use of antibiotics.
The development of the AMBP Programme has been led by NOAH in partnership with a group of stakeholders from across the industry including farmers, vets, the Responsible Use of Medicines in Agriculture Alliance (RUMA), the Veterinary Medicines Directorate (VMD), the British Retail Consortium (BRC) and leading academics, to create a training programme for all those working in the sheep, dairy, beef and pig sectors.
NOAH says the programme will raise awareness, knowledge and understanding of antimicrobial resistance (AMR) and help drive best practice in a consistent manner across UK farms when it comes to using antibiotics.
Training modules are available for farmers to access via the NOAH website or directly through an online Lantra eLearning platform.
In addition to the direct farmer offering, veterinary surgeons will also be to access resource materials, enabling them to deliver training to their clients. This veterinary resource centre will follow soon.
NOAH Chair, Gaynor Hillier, said: "We know that there is a real demand for this type of accessible training and we’re delighted to be able to lead the way in making it available.
"This new collaborative, cross-sector strategy on training will support both farmers and vets, demonstrating that our farmers have the skills to use antibiotics responsibly, providing reassurance to consumers and policy makers. NOAH is happy to be building on existing antibiotic stewardship achievements within the farming sector as ensuring best practice is vital to safeguard the future efficacy of antibiotics for us all.”
Biosecurity Minister Lord Gardiner said:
"The UK is at the forefront of global efforts to tackle antibiotic resistance. Recent statistics show there has been a 27 per cent drop in use of antibiotics in food-producing animals in the UK since 2014 - meeting a government commitment two years early.
"Our farmers and vets must be commended for driving down antibiotic use in livestock to this all-time low - setting an excellent example for others around the world to follow. But it is vital we continue making progress.
"We welcome this new responsible use of antibiotics farmer training programme, which will support the animal medicines industry to take another positive step towards tackling resistance, safeguarding antibiotics for future generations."
Photo: Lord Trees introduced the launch event and outlined his support for the AMBP programme.
To enter the competition, click here and list the BRD risk factors you can see.
The competition closes on 8th February 2019, when ten gilet winners will be picked at random from those entries that contain the most risk factors.
After the competition ends, you will also be able to download the cartoon for use in your practice and with your farming clients.
The main changes announced today are:
In the future, the revalidation interval, which currently ranges from two to five years depending on the course, will be standardised at 4 years.
Currently, there is a two-month window in which Official Veterinarians (OV) can submit their final declarations, on completion of the course, if they want to set their next revalidation interval from the end of the window.
The revalidation window will be extended to a six-month period prior to the completion deadline date. If completed in this window, the date of the next revalidation would be taken from the deadline date and not the date of completion.
APHA is discussing ways of making invigilation more flexible, to help those working in sole-charge or remote practices. One option being investigated with course accreditation providers is remote invigilation, though this would come at extra cost.
All the multiple choice questions in the online exams are being reviewed to make sure they test the ability to perform the role, and in the future, candidates will be given more feedback at the end of the test (ie which questions they answered incorrectly).
In terms of CPD requirements, there will be clarification on what can be considered relevant CPD towards the 10 hours that need to be completed over the four-year timeframe.
Lastly, APHA has announced a raft of changes concerning course content, and that it will itself review all the courses to consider how the number of courses and topics can be rationalised, how to reduce the number of qualifications any OV might need and/or the time spent revalidating, and how to reduce the content without losing quality.
The BVA, which spearheaded the campaign for reform, has welcomed the announcement. Simon Doherty, BVA President, said: "We’re delighted that APHA has taken on board our members’ concerns with the current system and proposed improvements that should make the process much more fair and consistent while continuing to maintain high standards. This is a really crucial time for ensuring that the workforce retains skilled professionals and is at full strength to keep animal welfare standards high, protect public health and meet demand for export certification after Brexit.
"This piece of work is a shining example of what can be achieved when vets pull together to air concerns and make the case for change. We will continue to work closely with APHA to explore and put in place ways of making the revalidation process as fit for purpose as possible for this critical section of the workforce."
Full review: http://apha.defra.gov.uk/documents/ov/Briefing-Note-0519.pdf
Whilst you're here, take a moment to see our latest job opportunities for vets.
Norbrook Laboratories has launched a ready-to-use suspension version of its Cefenil antibiotic.
Cefenil RTU (ceftiofur) is a 50mg/ml suspension for injection, indicated for cattle and swine.
Dr Barry McInerney, Norbrook's GB Veterinary Advisor said: "Cefenil RTU is a broad spectrum injectable antibiotic offering fast and effective treatment of bacterial respiratory disease, foot rot and acute post-partum metritis in cattle as well as bacterial respiratory disease in swine. It offers a zero milk withhold and a 5-day meat withhold which is the shortest on the market."
Norbrook's Cefenil Powder and Solution for Injection has been available for a number of years for the treatment of cattle and swine. It has recently been indicated for the treatment of BRD in horses in the UK. Cefenil RTU will offer vets an additional choice in the treatment of BRD.
Dr McInerney added: "Cefenil is a tried and tested antibiotic which vets have been using for a number of years. We are delighted to extend the Cefenil range with a RTU suspension for cattle and pigs and adding an indication for horses to our Cefenil Powder and Solution for Injection. It gives vets a wider choice for the treatment of BRD with a product with which they are already familiar."
For further product information, visit www.norbrook.com.
Developed by Nottingham Vet School’s Ruminant Population Health Group, the calculator is an online tool that veterinary surgeons and farmers can use 'in the field' to measure and monitor their prescribing and use of antibiotics in dairy cattle. It is available to download free at: https://dairy.ahdb.org.uk/technical-information/animal-health-welfare/amu-calculator/
The development follows a new study by the Nottingham Vet School showing that, in a large sample of dairy farms, 25% of farms used 50% of the total antibiotics used across all farms in a year – with antibiotic footbaths accounting for the biggest volume dispersed into the food chain. The study is published in the Veterinary Record1.
Senior Clinical Training Scholar and veterinary surgeon Robert Hyde said: "We felt it was crucial to provide the means with which to benchmark antimicrobial usage on farms, so that veterinarians and farmers can begin to monitor, and reduce, their levels of antimicrobial usage in a rational manner.
"Our new study provides the first published research into antimicrobial use in British dairy herds as well as factors associated with high usage. We looked at a sample of 358 dairy farms, over a 12-month period, with the total number of cattle being around 81,000 (7% of dairy cows in England). The survey found that most of the antibiotic use was via injections, which accounted for around 78% of the total antibiotics used or sold to the farms."
"What stood out as particularly surprising was the effects of the use of antibiotics in footbaths for conditions like digital dermatitis. Footbaths for cattle can use phenomenal quantities of antimicrobials, and represent an obvious target for the rapid reduction of antimicrobial usage."
Specialist cattle vet and Clinical Assistant Professor John Remnant from Nottingham Vet School said: “We need to be reducing the use of antibiotics on farms to the lowest level we can, but without failing to treat sick animals and reducing welfare standards. This means preventing disease – an area our research group has worked on for many years. Antibiotic use on UK dairy farms has been falling in recent years, as farmers and vets make efforts to turn towards prevention instead of treatment.
"The government has recently published figures showing the sale of antibiotics for food-producing animals has fallen from 62mg per kg of animal to 45mg per kg in the past two years but this is sales, not usage as we know some of the antibiotic products bought won’t be used. This is why our new study combined with the new online AMU tool is so important in helping farmers and vets instigate a more efficient protocol for the treatment of dairy cattle."
Edward Bailey from the George Veterinary Group in Wiltshire is already using the AMU calculator. He said: "This new tool is proving really useful to compare antimicrobial use between farms. It has helped cut through the confusion of different systems of measurement. It has been easier to effect change being able to display graphically to farmers their critically important antimicrobial usage and how particular patterns of use (e.g. footbath) can hugely affect how they compare with others."
Around 50 veterinary practices have already begun using the AMU calculator but the researchers say that antimicrobial benchmarking needs to happen a national level for the system to have maximum impact on antibiotic use in the cattle sector.
The company says it has redesigned the packaging to make it more distinctive, the idea being that it makes stock control in the practice and vaccine management on the farm easier and it also makes it easier for veterinary surgeons to identify and grab the right product off the shelf.
The new, bright red packaging for Bovilis IBR Marker Live is shown right. What do you think? Comment below.
Bovalto Respi vaccines contain a newly developed combination of viral and bacterial antigens. Merial says the recent vaccine isolates effectively target current European-circulating Bovine Respiratory Disease (BRD) strains. Bovalto antigens are also proven by challenge, including at six months post-vaccination to confirm long-lasting protection.
Henry Berger, Global Head of the Ruminant and Equine Business Unit at Merial, said: "Merial is committed to understanding the needs of cattle producers and delivering unique, targeted solutions. Merial is dedicated to expanding its portfolio of parasiticides, vaccines and other disease prevention solutions, with high-value products like Bovalto Respi, to improve productivity, and keep herds healthy."
Merial highlights that BRD is complex to manage and each year affects an estimated 1.9 million animals1, costing the UK cattle industry around £60 million2. In Ireland BRD is responsible for 30% of deaths in stock under one-year old3.
At a Merial symposium at WBC 2016, Prof. Sandro Cavirani, Director of the Department of Animal Health at the University of Parma, Italy highlighted the importance of successful BRD control programmes in calves to optimise herd immunity and productivity, including early, repeated and targeted BRD vaccination.
Bovalto Respi 3 contains strains of Parainfluenza Virus 3, Bovine Respiratory Syncytial Virus, and Mannheimia haemolytica serotype A1. The combination in Bovalto Respi 4 combines the three pathogens in Bovalto Respi 3, with the added strain of Bovine Viral Diarrhoea Virus (BVDV).
References
The review was recommended to Council by its Standards Committee following its exploration of the implications of new technologies for both animal health and welfare and veterinary regulation.
The main areas under consideration are the interpretation and application of an animal being under the care of a veterinary surgeon, and the provision of 24-hour emergency cover.
The College says that during the course of its research, which included numerous meetings and reports, a public consultation and examination of external legal advice, the Committee identified a number of anomalies in the College’s existing guidance that could affect how the Code’s provisions were applied across a range of different scenarios.
Chair of the Standards Committee, Dr Kate Richards, said: "It became clear to us that we could not consider telemedicine and remote prescribing in isolation and that it raised broader questions around the appropriateness of, and justification for, certain elements of existing RCVS guidance. I’m therefore pleased that RCVS Council has decided that the right and responsible approach is first to conduct a full review of these provisions."
The College anticipates that the review will require wide engagement from all relevant sectors, potentially including a Select Committee-style hearing in certain areas. This, it says, would help to ensure any decision to treat different groups differently, in relation to 'under care' and 'out-of-hours', is both reasoned and justified.
In the meantime, the College says that the current provisions of the RCVS Code of Professional Conduct and its supporting guidance remain in full effect.
Further information about the review will be made available in due course.
UPDATE (19/06/2019)
Following a number of concerns raised by members of the profession about this story, the RCVS has issued a further statement as follows:
We would like to acknowledge and address a number of concerns that have arisen amongst the profession following RCVS Council’s discussion last week that followed up queries raised during the previous debate in November, around the provision of telemedicine services, including remote prescribing.
The RCVS Council decision, made unanimously, was to proceed with a wide-ranging review of RCVS supporting guidance concerning 24-hour emergency cover and the interpretation and application of ‘under veterinary care’, and to postpone the proposed telemedicine trial for the foreseeable future and certainly until the conclusion of this review. The review will encompass, but not be limited to, consideration of what restrictions or safeguards to place on remote prescribing in the form of vet-to-client telemedicine.
RCVS Council discussed this paper ‘in committee’ in order to be able to examine the confidential legal advice it had requested at its previous meeting. The decision to hold these discussions privately was purely related to the privileged nature of legal advice and in no way related to any ‘commercial interests’.
We recognise fully that this is a complex issue, with strong views held on all sides. However, it is entirely right and proper for RCVS Council members to be able to discuss and debate such topics in detail, before reaching a decision through a vote. In the course of such discussions, issues may arise that had not previously been identified, and which may alter the original direction of thinking.
We appreciate that Council’s decision was perhaps unexpected, especially as the original topic had been under consideration for some time. This is why we announced it as soon as possible, along with an indication of what Council would like to happen next.
Whilst it is far too early to have worked out the details of the agreed review, it will be open and inclusive in parallel with our previous consultations, which continue to receive considerable levels of engagement across the veterinary professions and wider industry stakeholders.
We will publish full details about our plans for this review over the coming weeks, and will continue to work hard to engage all veterinary professionals in these important decisions.
Veteran campaigner and RCVS Councillor Danny Chambers MRCVS (pictured right) has started a petition to George Eustice on change.org that: Future trade deals must not compromise animal welfare and public health.
The petition has gathered an impressive 21,984 signatures, of which Danny says that more than 500 are from veterinary surgeons.
Meanwhile VetPartners is calling on the retail and food service sector to give priority to British produce, even if future trade deals enable the import of foods produced to lower standards.
Ian Cure, farm director at VetPartners, is contacting the UK’s main retailers to discuss how they can support British farmers in the months and years to come. He has the backing of the clinical directors at each of the 28 farm or mixed practices within the group, which collectively look after the health and welfare of over 30% of the UK’s dairy population and 45% of the pig population.
“We are asking retailers to prioritise a range of Red Tractor certified produce at varying prices, while avoiding designating shelf space to imports of a lower quality. Likewise, the food service sector can choose to source from UK food supply chains.
“These sectors have a high level of influence, as consumers will pick from what is clearly available, which is why we see it as the best way to support our farmers.
“We are incredibly concerned about how the higher welfare and production standards in UK agriculture will be protected long term, given that MPs failed to enshrine that protection in law when voting against the recent amendment to the Agriculture Bill last month.
“Future trade deals to allow the import of cheap food from countries outside of the EU would be a step in the wrong direction, as our farmers will not be competing on an even playing field as they attempt to compete with countries with lower costs of production.”
However, Ian adds that this is not just a welfare issue: "If the UK livestock sector is forced to adopt practices that are frowned upon in Europe to compete, such as the American applications of hormone growth treatments and chlorinated chicken, we would be severely risking our local, lucrative European export market.
“While trade with countries such as the USA and Australia may have benefits from an economical perspective, the carbon emissions associated with longer distance transport of food is a real concern.
“We see it as imperative that higher welfare standards are maintained, while reducing the carbon footprint of our food supply – it's the right, sustainable thing to do. As MPs have let down the sector, we are now calling on retailers and the food service industry to back UK farming."
The BSAVA has announced the launch of a free new online publication: BSAVA Guide to the Use of Veterinary Medicines
Edited by Fred Nind and Pam Mosedale, with contributions from experts in the field, has been developed to provide a comprehensive guide to a wide variety of veterinary medicines issues that affect small animal practice. It looks like a very polished production, and should prove a valuable tool for all members of the practice team.
Many infringements of the law relating to the possession, use and disposal of veterinary medicines are criminal offences, and it was the aim of the Editors to produce an authoritative guide to help practitioners stay on the correct side of the law in an area where this can sometimes be problematic.
LegislationAs Fred and Pam noted in the March 2009 issue of Companion: 'Veterinary Medicines Regulations (VMR) change every year, whilst waste disposal provisions and dangerous drugs regulations seem to be updated even more often. This means that what you learned at a course attended last year or from a booklet published two years ago may no longer be accurate.' The format of the BSAVA Guide to the Use of Veterinary Medicines, means that it is capable of being updated as the rules and regulations change, helping veterinary surgeons, nurses, practice managers, receptionists, students and kennel staff to get it right - first time and every time.
StorageEfficient stock control, ambient storage conditions, stock rotation based on expiry dates and correct labelling are just some of the areas that need to be addressed when considering management of the practice dispensary. The section of the guide on Correct storage and dispensary management provides recommendations on how this can be achieved.
DispensingPrescribing and labelling veterinary medicines are activities that every practitioner performs many times a day, and it is important that the detailed legal provisions governing these actions are adhered to. Covering such areas as: who may write a prescription; breaking packaging; and the additional regulations that apply for the supply of Controlled Drugs, the Prescribing and labelling section helps guide the practitioner through this complicated area.
The BSAVA Guide to the Use of Veterinary Medicines is available to all, not just BSAVA members, and the Editors hope will 'provide balm for all those worrying about the practical and legal constraints on the use of veterinary medicines.'
Click here to download the BSAVA Guide to the Use of Veterinary Medicines (pdf 5mb)
Intervet/Schering-Plough Animal Health has launched a new oxytetracycline spray which the company says offers more accurate antibiotic delivery whether the can is used in an upright or inverted position.
Alasdair King MRCVS, Intervet/Schering-Plough Animal Health veterinary manager, says new Engemycin Spray has been developed specifically to address problems reported with traditional aerosol cans:
"Antibiotic sprays are used widely, yet they can become a practical nuisance to both vets and farmers simply because many cans do not perform satisfactorily. All too frequently the nozzle leaks or detaches, the spray pattern is irregular - particularly if the can is held upside down as it so often needs to be - or the valve clogs before the can is empty. This can be a source of great frustration to users, but new Engemycin Spray overcomes all these problems."
Intervet/Schering Plough says Engemycin Spray combines a unique, quick-drying formulation with an innovative, non-clogging spray valve. The quick-drying formulation minimises wastage from the sprayed area, while the new valve - which works as well when the can is upside down - cuts spraying time and ensures more reliable and constant delivery of antibiotic. The valve is unique and designed to enable the can to fully empty.
Engemycin Spray is licensed for the treatment of foot and wound infections in cattle, sheep or pigs following surgery or physical injury. The new product is available now from wholesalers.
The manufacturer has identified that there is a potential for decreased levels of the preservative Chlorobutanol hemihydrate in the following batch: J2101-03 Expiry 11/2018.
Oxytobel is distributed in the UK by Bimeda UK. Veterinary practices that have purchased this batch number should contact Bimeda to arrange collection.
Any queries in relation to return of the product or credit for the product returned should be addressed to Kay Cowton, Bimeda UK Sales on 01248 725400 or email: uksales@bimeda.com
For further information on the recall please contact Bela-pharm GmbH & Co.KG: +49 (0) 44 41 873 294.